Get access

Guidelines for the management of alopecia areata

Authors

  • S.P. MacDonald Hull,

    1. Pontefract General Infirmary, Pontefract WF8 1PL, U.K.
      *Rotherham District General Hospital, Rotherham S60 2UD, U.K.
      †Leicester Royal Infirmary, Leicester LE1 SWW, U.K.
      ‡Royal Hallamshire Hospital, Sheffield S10 2JF, U.K.
    Search for more papers by this author
  • M.L. Wood,

    1. Pontefract General Infirmary, Pontefract WF8 1PL, U.K.
      *Rotherham District General Hospital, Rotherham S60 2UD, U.K.
      †Leicester Royal Infirmary, Leicester LE1 SWW, U.K.
      ‡Royal Hallamshire Hospital, Sheffield S10 2JF, U.K.
    Search for more papers by this author
  • P.E. Hutchinson,

    1. Pontefract General Infirmary, Pontefract WF8 1PL, U.K.
      *Rotherham District General Hospital, Rotherham S60 2UD, U.K.
      †Leicester Royal Infirmary, Leicester LE1 SWW, U.K.
      ‡Royal Hallamshire Hospital, Sheffield S10 2JF, U.K.
    Search for more papers by this author
  • M. Sladden,

    1. Pontefract General Infirmary, Pontefract WF8 1PL, U.K.
      *Rotherham District General Hospital, Rotherham S60 2UD, U.K.
      †Leicester Royal Infirmary, Leicester LE1 SWW, U.K.
      ‡Royal Hallamshire Hospital, Sheffield S10 2JF, U.K.
    Search for more papers by this author
  • A.G. Messenger

    1. Pontefract General Infirmary, Pontefract WF8 1PL, U.K.
      *Rotherham District General Hospital, Rotherham S60 2UD, U.K.
      †Leicester Royal Infirmary, Leicester LE1 SWW, U.K.
      ‡Royal Hallamshire Hospital, Sheffield S10 2JF, U.K.
    Search for more papers by this author

  • These guidelines were commissioned by the British Association of Dermatologists Therapy Guidelines and Audit subcommittee. Members of the committee are N.H.Cox (Chairman), A.S.Highet, D.Mehta, R.H.Meyrick Thomas, A.D.Ormerod, J.K.Schofield, C.H.Smith and J.C.Sterling.

Andrew Messenger.
E-mail: a.g.messenger@sheffield.ac.uk

Summary

These guidelines for management of alopecia areata have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

Ancillary